Arbekacin Treatment of Adult Patients With Infections Caused by Multidrug-resistant Bacteria

NCT01659515 · clinicaltrials.gov ↗

NO_LONGER_AVAILABLE

Status

FED

Sponsor class

Conditions

Infection Due to Resistant Organism

Interventions

DRUG: Arbekacin Sulfate

Sponsor

U.S. Army Medical Research and Development Command

Collaborators

[object Object]
[object Object]